Tablets combining DPP-4 inhibitor linagliptin and metformin HCl for managing type 2 diabetes in adults. Sourced from global and local drug manufacturers by B2B platforms, utilized in hospital formularies and community pharmacies for prescriptions by endocrinologists and primary care teams.